Avenue Growth Partners Closes $155M Fund II for Vertical AI Software
TL;DR
Avenue Growth Partners has closed an oversubscribed $155 million Fund II at its hard cap, nearly doubling its $83 million debut and blowing past a $125 million target. The growth-equity firm, co-founded by Ryan Russell and Brian Goldsmith, runs a deliberately concentrated book of early growth-stage vertical software companies that use AI to automate complex, domain-heavy workflows in industries like labs, trucking, legal and equipment dealerships. A blue-chip LP base, including Accolade Partners, Fairview Capital, GCM Grosvenor, Partners Capital and The Metropolitan Museum of Art, signed on as the firm posted early wins from Fund I.
Key Takeaways
Concentration is the strategy, not a constraint. Avenue is explicit that a small, high-conviction portfolio is core to its model, giving every founder "full attention." In a growth-equity market drifting toward index-like check-writing, a concentrated vertical-AI book is a genuine differentiator, and a bet that operational involvement drives returns.
Vertical AI is the thesis of the moment, and Avenue was early. The firm targets software serving markets where domain expertise creates barriers to entry, exactly the "boring" verticals where AI-native products can now automate workflows that were previously too specialized to touch. That is where the next durable software franchises are most likely to compound.
The LP roster punches above the fund size. Accolade, Fairview, GCM Grosvenor and Partners Capital are sophisticated, access-constrained allocators; the Met's endowment adds an unusually prestigious name. For a sub-$200M Fund II, that is institutional validation most managers take three funds to earn.
Early liquidity signals are already showing. Two Fund I companies, Hive and Minga, have completed recapitalizations with later-stage growth and buyout firms, giving Avenue tangible mark-ups and partial realizations to point to while raising, a rare luxury for a second-time fund.
Fund Overview
Fund Name: Avenue Growth Partners Fund II
Fund Size: $155 million (hard cap, oversubscribed; $125M target)
Stage: Early growth-stage / growth equity
Check Size: Concentrated positions; recent deals led $8M-$10M Series A rounds
Geography: United States
Focus: Vertical software and AI-enabled platforms for specialized industries (labs, trucking, legal, equipment dealerships)
Key LPs: Accolade Partners, Fairview Capital, GCM Grosvenor, Partners Capital, The Metropolitan Museum of Art
Why This Fund Matters
The most contested question in software investing right now is whether AI compresses the value of application-layer companies or expands it. Avenue is placing a clear bet on expansion, specifically in verticals where general-purpose models still fail without deep domain context, proprietary workflows and integration into legacy systems. A life-sciences lab or a trucking back office cannot simply bolt a chatbot onto its operations; it needs software that encodes the industry's rules. That is a defensible place to invest AI capital, and it is where Avenue has concentrated.
The fund's size and structure are as much a statement as its thesis. At $155 million with a concentrated model, Avenue is deliberately staying small enough to matter to each portfolio company and to preserve fund-returning ownership, resisting the gravitational pull toward ever-larger vehicles that dilutes growth-equity returns. In a period when many managers raised bigger funds and quietly loosened discipline, choosing a hard cap below what demand would have allowed is a credibility move.
It also lands at a moment when LP capital is scarce and selective. The first half of 2026 saw venture fundraising concentrate in a handful of mega-funds, making an oversubscribed close by a second-time manager genuinely notable. The quality of the LP base suggests allocators are rewarding differentiated, disciplined strategies over generalist scale.
Finally, the early recapitalizations of Hive and Minga matter beyond the mark-ups. They validate a full lifecycle: Avenue can enter at early growth, add operational value, and hand companies to later-stage capital or buyers. For a strategy predicated on hands-on partnership, demonstrating that the model produces liquidity, not just paper, is the whole game.
The Team
Avenue Growth Partners was co-founded by Ryan Russell and Brian Goldsmith, who both serve as partners and are the public voices of the firm's strategy. Russell frames the concentrated-portfolio model as the mechanism that lets the firm help founders "win their category," while Goldsmith articulates the AI thesis directly: that small teams can now build deeply embedded products in industries historically too complex or specialized to automate. The pairing of a disciplined portfolio-construction philosophy with a specific, technically grounded view of where AI creates new software categories is the firm's core identity.
Early Portfolio
Fund I produced two notable early outcomes, with Hive and Minga each completing recapitalization transactions alongside later-stage growth-equity and buyout firms. From Fund II, Avenue has already led the $8 million Series A for Scispot, which is building an AI-native operating platform for life-sciences laboratories, and the $10 million Series A for Billables AI, an AI-powered timekeeping and revenue-operations platform for law firms. Both fit the pattern precisely: specialized industries, complex workflows and AI-native software as the wedge.
What This Means for Founders
If you are building vertical software for a complex, unglamorous industry and you want an investor who will be deeply involved rather than one of twenty logos on your cap table, Avenue is close to an ideal fit. The firm's concentration means it invests real time per company, and its recent Series A leads show it will anchor rounds rather than merely follow. Founders in labs, logistics, legal, industrial distribution and similar domains, where operational knowledge is the moat, should be on Avenue's radar.
The flip side of concentration is selectivity. A small portfolio means few slots and a high bar, and "early growth-stage" implies Avenue wants established product-market fit and recurring revenue, not a pre-seed idea. If you are earlier than that, this is a relationship to build over time rather than a check to expect today. Founders who fit the profile, though, get an unusually engaged partner with fresh capital and demonstrated ability to steer companies to their next stage.
Fund Momentum Take
Avenue is running one of the more coherent playbooks in growth equity right now: a specific, defensible thesis, a portfolio-construction discipline that aligns with it, and an LP base that signals real institutional conviction. Everything about this raise, from the modest hard cap to the quality of the allocators, suggests a manager optimizing for returns per dollar rather than assets under management. That is the correct instinct, and increasingly rare.
The risk sits inside the thesis itself. Vertical AI is now consensus, which means valuations in the exact categories Avenue targets are rising and competition for the best founders is intensifying. Concentration amplifies both the upside and the downside: a small number of misjudged category bets hurts more when each position is meant to move the fund. Avenue's edge has to be genuine operational value and category selection, not just access.
Our bet: this is a franchise being built the right way, and the early recaps suggest the model works end to end. If Avenue holds its discipline and resists the temptation to balloon Fund III, it has a credible path to becoming a go-to specialist for vertical-AI growth rounds. The thing to watch is whether it can keep winning its target companies as the category gets more crowded and pricier.
Frequently Asked Questions
How large is Avenue Growth Partners Fund II?
$155 million, closed oversubscribed at its hard cap, up from an $83 million debut fund and above the original $125 million target.
What does Avenue invest in?
Early growth-stage vertical software and AI-enabled platforms for specialized industries such as life-sciences labs, trucking, legal services and equipment dealerships.
Who are the LPs?
Investors include Accolade Partners, Fairview Capital, GCM Grosvenor, Partners Capital and The Metropolitan Museum of Art, alongside public pensions, foundations and family offices.
What has the firm invested in recently?
Fund II has led the $8 million Series A for Scispot (life-sciences lab software) and the $10 million Series A for Billables AI (legal timekeeping and revenue operations).
Who founded Avenue Growth Partners?
Co-founders and partners Ryan Russell and Brian Goldsmith lead the firm.
Have a fund closing to announce? Submit your fund here.
Need help raising capital? Check out our Fundraising Advisory services.